1. Home
  2. EIG vs PHAR Comparison

EIG vs PHAR Comparison

Compare EIG & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EIG

Employers Holdings Inc

HOLD

Current Price

$45.54

Market Cap

793.6M

Sector

Finance

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$12.37

Market Cap

925.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EIG
PHAR
Founded
2000
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
793.6M
925.2M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
EIG
PHAR
Price
$45.54
$12.37
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$38.33
AVG Volume (30 Days)
164.6K
14.5K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
2.99%
N/A
EPS Growth
N/A
N/A
EPS
0.52
N/A
Revenue
$858,700,000.00
N/A
Revenue This Year
N/A
$10.04
Revenue Next Year
$1.26
$2.51
P/E Ratio
$85.52
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$35.73
$9.54
52 Week High
$47.91
$21.34

Technical Indicators

Market Signals
Indicator
EIG
PHAR
Relative Strength Index (RSI) 75.02 44.13
Support Level $41.01 $12.98
Resistance Level $46.25 $13.61
Average True Range (ATR) 0.91 0.39
MACD 0.17 0.09
Stochastic Oscillator 100.00 63.99

Price Performance

Historical Comparison
EIG
PHAR

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations through its wholly owned subsidiaries.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: